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Abstract
Zearalenone (hereafter referred to as ZEA) is a nonsteroidal estrogenic mycotoxin produced by several Fusarium spp. on
cereal grains. ZEA is one of the most hazardous natural endocrine disrupting chemicals (EDC) which induces hyper
estrogenic responses in mammals. This can result in reproductive disorders in farm animals as well as in humans.
Consequently, detoxification strategies for contaminated crops are crucial for food safety. In this study we have developed a
bacterial based detoxification system using a non-pathogen Rhodococcus pyridinivorans K408 strain. Following 5 days
treatment of ZEA with R. pyridinivorans K408 strain HPLC analyses showed an 87.21% ZEA-degradation efficiency of the
bacterial enzyme systems. In another approach, the strain biotransformation ability has also been confirmed by a
bioluminescent version of the yeast estrogen screening system (BLYES), which detected an 81.75% of biodegradability of
ZEA, in a good agreement with the chemical analyses. Furthermore, the capacity of R. pyridinivorans to eliminate the
estrogenic effects of ZEA was tested by using an immature uterotrophic assay. Prepubertal female rats were treated with
vehicle (olive oil), 17b-estradiol, ZEA (0.1-1-5-10 mg/kg body weight) and LB broth containing 500 mg/l ZEA that has already
been incubated with or without Rhodococcus pyridinivorans K408 strain. Uterine weights were measured and the mRNA
level changes relating to apelin, aquaporin 5, complement component 2, and calbindin-3 genes were measured by qRT-PCR.
These genes represent the major pathways that are affected by estromimetic compounds. Zearalenone feeding significantly
increased the uterus weight in a dose dependent manner and at the same time upregulated complement component 2 and
calbindin-3 expression as well as decreased apelin and aquaporin 5 mRNA levels comparable to that seen in 17b-estradiol
exposed rats. In contrast, LB broth in which ZEA was incubated with Rhodococcus pyridinivorans K408 prior to the feeding
did not display any estrogenic effect neither on uterine weight nor on the expression of estrogen-regulated genes.
Consequently, the identification of Rhodococcus pyridinivorans K408 strain in ZEA biodegradation proved to be a very
efficient biological tool that is able to eliminate the complete estrogenic effects of ZEA. It is also remarkable that this
biotransformation pathway of ZEA did not result in any residual estrogenic effects.
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Introduction
Zearalenone (ZEA, previously known as F-2 toxin) is an
estrogenic mycotoxin produced by several Fusarium spp. species.(F.
graminearum (Gibberella zeae), F. culmorum, F. equiseti, F. crookwellense,
and F. semitectum) [1]. ZEA is found worldwide in a number of
cereal crops such as maize, barley, oats, rice and sorghum and it is
heat stable, hence the processing of raw materials in food industry
does not eliminate ZEA and the toxin remains in the end-product,
in bread for example [2,3]. Consequently ZEA represents both a
health risk and an economic problem. The rapid growth of the
human population requires the development of a cost effective and
safe decontamination processes for raw materials and feed to
reduce the post harvesting loss.
ZEA binds to both forms of estrogen receptor, ER-a and ER-b
(ERs) in vitro with similar affinity [4–5]. In vivo, ZEA is rapidly
absorbed after oral administration [2] and metabolized into two
major metabolites, a-zearalenol (a-ZOL) and b-zearalenol (b-
ZOL), which are also ligands of ER [6]. The metabolite a-ZOL
shows higher estrogenicity than ZEA, by contrast b-ZOL was less
effective in MCF7 proliferation test [7].
Acute effects of ZEA are vulva vaginitis and enlarged
reproductive tracts in females and atrophy of the seminal vesicles
and testes in males [8]. The female reproductive system is more
sensitive to ZEA than males, mainly in the prepubertal age.
Prepubertal ZEA administration causes accelerated vaginal
opening, persistent estrus and sterility [9]. Furthermore, exposure
of zearalenone has the effect of reducing fertility and litter size in
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domestic animals [10] and ZEA mycoestrogens have been
suspected as triggering factors for central precocious puberty in
girls [11]. It should be noted that ZEA has a relatively low acute
toxicity (oral LD 50 values of .2000–20000 mg/kg body weight.)
after oral administration in mice, rats and guinea pigs. Pigs and
sheep appear to be more sensitive than rodents; in controlled
studies with a well-defined exposure to multiple ZEA doses [2].
ZEA and derivatives showed similar estrogenic properties, with the
exception of a-ZOL which induced a higher estrogenic activity
[12].
To eliminate health- and economic threats that occur as a result
of these toxins, detoxification procedures are needed as a matter of
urgency. There are many microbes that are capable of degrading
mycotoxins [13], for instance, actinomycete strains – especially
rhodococci [14], are the best aflatoxin degraders. ZEA has also been
shown to be eliminated by Acinetobacter sp. SM04 [15] and also by
Pseudomonas putida ZEA-1 [16]. Recently, several microbes from
hydrocarbon contaminated sites have been isolated in Hungary
and deposited in the strain collection of Agruniver Holding Ltd.
(Rhodococcus pyridinivorans K408 strain: GenBank accession number:
jx021450). The mycotoxin degradation capacity of these strains
has been confirmed in previous studies [17]. As such, the possible
endocrine effects of the degraded ZEA products require analysis
by effective testing methods.
For the measurement of estrogenic effects, the estrogen
bioindicator yeast strain YZRM7 [18] or HitHunter EFC estrogen
chemiluminescence assay kit (DiscoveRx/Amersham Biosciences)
could be utilised. Recently, a fast, simple, cost-effective lumines-
cence based yeast estrogen screen (BLYES) was developed to
reveal harmful biological effects of EDCs [19,20]. By integrating a
human estrogen receptor into the genome, along with bacterial lux
cassette on plasmids, the Saccharomices cerevisiae BLYES strain has
been engineered. The presence of moieties that bind to the
estrogen receptor result in an increased bioluminescence of the
tester strain, which seems to be a valuable tool for analyzing ZEA
levels. In our study the BLYES test was performed to detect the
estrogen effects of the metabolites produced.
However, apart from the in vitro screening methods, in vivo
studies are also needed to investigate biodegradation efficiency
directly on the neuroendocrine system. For this purpose the
application of a rodent based uterotrophic bioassay can be the
most suitable approach, in which two markers are measured: the
uterine weight and changes in the estrogen-dependent gene
expression in the uterine tissue. Uterine weight gain after
treatment with different ECDs has been previously described
[21] It has been shown that estrogen and compounds with
estrogen-like effects regulate several pathways in uterine tissue.
The main regulated pathways are the remodeling of extracellular
matrix, alternative complement activation, cell proliferation and
estrogen-mediated calcium signaling. As such, these estrogen-
receptor-mediated alterations in gene expression, demonstrated by
a microarray study, and the results, which can be validated by
quantitative real-time PCR measurement [22] are useful markers
to elucidate the biodegradation processes.
In this study our aim was to develop an efficient biotransfor-
mation procedure for ZEA degradation with Rhodococcus pyridini-
Figure 1. Remained estrogen effect in the zearalenone metabolism of Rhodococcus pyridinivorans analysed by the bioluminescens
yeast reporter system (BLYES). The results show that the incubation with Rhodococcus pyridinivorans K408 decreased the estrogenic activity of
zearalenone. After 5 days, remained estrogen effect was 81.75% compared to control. The results of the BLYES based estrogenic biotest showed
good correlation with ZEA concentration measurement via HPLC-FLD.
doi:10.1371/journal.pone.0043608.g001
Figure 2. Blood plasma ZEA concentrations in Experiment 1.
Blood plasma ZEA concentrations in female immature rats after 3-day
exposure to different dosage of ZEA (0.1–10 mg/kg bw) was measured
by competitive fluorescent-microsphere based immunoassay (CFIA).
The results show that there was a dose dependent increase in plasma
ZEA concentration following oral administration. Blood plasma levels
showed a strong positive correlation (R = 0.919186) with uterus weight
in a dose dependent manner. (**) Significantly different from control
(p,0.001) (n = 6–7). (***) Significantly different from control (p,0.001)
(n = 6–7).
doi:10.1371/journal.pone.0043608.g002
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vorans K408 strain. At the same time we targeted the development
of a comprehensive monitoring in vitro -and in vivo system, in which
both the level of the degraded ZEA and the remaining effect of the
non-degraded ZEA on the neuroendocrine system can be
evaluated. The in vivo measurements comprised an uterotrophic
bioassay with prepubertal female rats.
Materials and Methods
2.1 Identification of strain K408
Genomic DNA was extracted from strain K408 using G-
spinTM Genomic DNA Extraction Kit (Intron Biotechnology
Inc., South Korea). For PCR-based 16 S rDNA multiplication
universal primers 27F, and 1492R were used [23]. PCR products
Figure 3. Uterine weights of Experiment 1 and Experiment 2. Uterotrophic response expressed as relative uterus weight (uterus weight/body
weight) in female immature rats after 3-day exposure to E2 (0.04 mg/kg bw) and ZEA (0.1–10 mg/kg bw) (A, Experiment 1) and after 3-day exposure
to ZEA-contaminated LB media with and without incubation with R. pyridinivorans K408 (B, Experiment 2). (***) Significantly different from control in
Experiment 1 (p,0.001) (n = 6–7). (**) Significantly different from control in Experiment 2 (p,0.01). (##) Significantly different from ZEA in Experiment
2 (p,0.01) (n = 6–8).
doi:10.1371/journal.pone.0043608.g003
Figure 4. Gene expression of apelin, aquaporin 5, complement component 2 and calbindin 3 in Experiment 1. Gene expression of apelin
(APLN) and aquaporin 5 (AQP5) decreased and complement component 2 (C2) and calbindin 3 (CALB3) increased significantly both by E2 0.04 mg/kg
bw and ZEA 10 mg/kg bw 3-day-long treatment. (*) Significantly different from control (p,0.05). (**) Significantly different from control (p,0.01)
(n = 6–7). (***) Significantly different from control (p,0.001) (n = 6–7).
doi:10.1371/journal.pone.0043608.g004
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were purified with the Viogene DNA/RNA Extraction Kit
(Viogene BioTek Corp., Taiwan). The almost complete 16 S
rRNA gene sequence of strain K408 was determined by using
BigDye Terminator v3.1 Cycle Sequencing Kit (Applied Biosys-
tems, USA) in accordance with the instructions of the manufac-
turer. Sequencing products were separated on a Model 310
Genetic Analyzer (Applied Biosystems). Primers used for 16S
rDNA sequencing reactions were 27F, 338F, 803F, 1492R [23].
The 16S rDNA sequence analysis were done by Blast tool, NCBI
[24] and by the use of Le BiBi server [25].
Almost complete (1355 bp) 16 S rDNA sequence of strain K408
was determined and submitted to GenBank under the accession
number jx021450. According to the Blast analysis with all the type
strains of rhodococci the highest similarity (99.85% ) was found
with Rhodococcus pyridinivoransT DSM 44555. Phylogenetic analysis
also confirmed the identification of the investigated strain as
LeBibi alignment clearly placed strain K408 to R. pyridinivorans
species. On the basis of genotypic data the zearalenone degrading
bacterium was identified as Rhodococcus pyridinivorans K408.
2.2 Biodegradation of Zearalenone by Rhodococcus
pyridinivorans K408
Cells of Rhodococcus pyridinivorans K408 strain were streaked on
LB agar plates and incubated at 28uC for 72 hours. Single colonies
were inoculated into 50 ml aliquots of, LB medium incubated at
28uC (170 rpm) for 48 hours. When the optical density of the
cultures reached 0.6 (OD550 = 0.6), 15 ml of this culture was added
into 135 ml sterile LB medium. ZEA (Fermentek, Israel), from
acetone stock, was added to the medium to a final concentration of
5 mg/ml. As a control, 150 ml bacterium free LB medium with 5
mg/ml ZEA was used. The growth media and controls, in three
parallels, were incubated in a shaking thermostat (170 rpm,
maintained at 28uC, for 5 days). Every 24 hours, 1ml samples
were taken and, centrifuged at 20.0006g, (4uC), for 20 min. Both
supernatant and pellet were stored at 220uC until required. The
remaining ZEA concentrations in samples of supernatant and
Figure 5. Gene expression of apelin, aquaporin 5, complement component 2, and calbindin 3 in Experiment 2. Gene expression of
apelin (APLN) and aquaporin 5 (AQP5) decreased and complement component 2 (C2) and calbindin 3 (CALB3) increased significantly after 3-day ZEA
treatment. There is no significant difference between control and ZEA + R. pyridinivorans K408 treatment in folding changes. (*) Significantly different
from control (p,0.05). (**) Significantly different from control (p,0.01). (#) Significantly different from ZEA (p,005). (###) Significantly different
from ZEA (p,0,001) (n = 6–7).
doi:10.1371/journal.pone.0043608.g005
Figure 6. Putative mechanisms of the ZEA biodegradation by
Rhodococcus pyridinivorans K408. The arising metabolites and the
zearalenone degradation mechanism of Rhodococcus pyridinivorans
K408 are unknown yet. However, previous studies suggest various ways
how zearalenone could be degraded by microbes. Trichosporon
mycotoxinivorans (1) and Clonostachys rosea IFO 7063 (2) are able to
open the lactone ring resulting non-estrogenic metabolites which are 1-
(3,5-dihydroxyphenyl)-109-hydroxy-1-undecen-69-one and (5S)-5-({2,4-
dihydroxy-6-[(1E)-5-hydroxypent-1-en-1-yl]benzoyl}oxy) hexanoic acid,
respectively. In addition, Rhodococcus pyridinivorans K408 have versatile
metabolic pathways and the most of them are able to degrade aromatic
compounds. It suggests that opening the aromatic ring is also a
possible way to degrade zearalenone (3).
doi:10.1371/journal.pone.0043608.g006
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pellet were analyzed by High Performance Liquid Chromatogra-
phy (HPLC) and BLYES.
2.3 Quantifying the Zearalenone level by HPLC analyses
High-performance liquid chromatography (HPLC). The
sample was diluted with water and cleaned on a ZearalaTest
immunaffinity column (VICAM). The ZEA was eluted with
methanol from the column.
After dilution with methanol: water (1:1) a 50 ml aliquot of the
sample was injected to the HPLC-FLD system (liquid chroma-
tography separation and fluorescence detection of toxins according
to AOAC Official Method 985.18). The separation was carried
out on a C18 column (Vydec Denali, 4.66150 mm; 5 mm) using
water: acetonitrile (45:55) under isocratic conditions. The ZON
was detected with extinction wavelength 274 nm and emission
wavelength 440 nm.
2.4 Determination of the Estrogen effect modulated by
ZEA in BLYES assay
The strain Saccharomyces cerevisiae BLYES, contains the human
estrogen receptor on its chromosome and the luminescence gene
cluster lux of Photorhabdus luminescens on two plasmids [20]. This
enables the detection of EDC by a simple luminescence
measurement.
S. cerevisiae strains BLYES were stored at 220uC and grown
overnight at 30uC (200 rpm) to an OD600 of 0.1, in a modified
minimal medium (YMM leu-, ura-) [26].
Supernatants of the biodegradation study were diluted five-fold,
in order to evaluate the estrogen effect in the linear region of the
dose-response curve of BLYES. Supernatants of ZEA biodegra-
dation were examined in 1:2 serial dilutions (sample concentration
of 100–3.13%) for their remaining estrogenic effect. This was
achieved by placing 20 ml of each of the biodegraded ZEA solution
into 96-well micro-titer plates (Grenier Bio-one) and subsequently
200 ml of S. cerevisiae culture (BLYES) was added into each well.
Bioluminescence was measured after 5 hours in a VictorX
Multilabel Plate Reader (Perkin Elmer, Hungary). Negative
controls included wells containing S. cerevisiae cultures (BLYES)
and wells containing cultures and solvent (acetone) LB medium
with 1 mg/ml ZEA was applied here as a positive control. For data
analysis, luminescence was determined with the following modified
formula (a):
Bioluminescence intensification %ð Þ
~ { C{Sð Þ100=C½ 
ðaÞ
where C is the arithmetic mean of the bioluminescence values of
parallel controls, after incubation, and S represents the biolumi-
nescence average value of parallel samples determined at the time
of contact.
2.5 Experimantal Animals in ZEA administration
Prepubertal female Wistar rats from a colony bred at the
Institute of Experimental Medicine (Budapest, Hungary) were
used. Animals were kept under controlled conditions (3 animals
per cage, at a temperature of 2161uC, and humidity at 65%). The
animals were illuminated for 12 hours per day (07:00–19:00
hours). Phytoestrogen free rat feed and untreated tap water were
available ad libitum.
Rats were weaned, weighed and allocated to treatment groups
at postnatal day 18 (PND 18). All experimental procedures were
performed in accordance with the European Communities
Council Directive of 24 November 1986 (86/609/EEC) and
Hungarian Government directive 243/98. Experiments were
approved by the Institutional Animal Care and Use Committee
of the Institute of Experimental Medicine.
2.6 ZEA administration of female rats and the
uterotrophic assay
An uterotrophic assay was performed using the validated
Organisation for Economic Co-operation and Development 440
(OECD) protocol on prepubescent rat.
E2 and ZEA solutions were prepared as follows: 1 mg of 17b-
estradiol, (E2, SIGMA) was dissolved in 50 ml 70% ethanol, and
then mixed with 5 ml olive oil. 10 mg ZEA (Fermentek, Israel) was
dissolved in 200 ml 96% ethanol then mixed with different
volumes of olive oil. Drugs were administered with oral gavages
(2 ml/kg body weight), daily starting at 09:00 hours. Treatment
groups were as follows: E2 (0.04 mg/kg bw, positive control), ZEA
(0.1-1-5-10 mg/kg bw) and the vehicle control (olive oil).
Treatment started at PND 18 and lasted for 3 consecutive days
(PND 18–20). At PND 21 rats were weighed and sacrificed by
decapitation, trunk blood collected and the uteri dissected and
weighed. One uterine horn was frozen immediately on dry ice,
and stored at 270uC, whereas the other horn was fixed in 4%
paraformaldehyde (0.1 M phosphate buffer) for histology.
Immediately after dissection, wet and blotted uterine weights
were obtained. Wet weight includes the uterus and the luminal
fluid contents. The blotted weight was measured after the luminal
contents of the uterus have been removed (by pressing). Wet uterus
weights were normalized to body weight.
2.7 Dose determination of Animal feeding experiments
investigating the efficiency of ZEA biodegradation
The treatment groups were the following: LB broth (control);
zearalenone-contaminated (500 ppm) LB broth; and zearalenone–
contaminated (500 ppm) LB broth, which was treated with R.
pyridinivorans K408. For the animal feeding experiments; Rhodo-
coccus pyridinivorans K408 strain degraded ZEA samples were
collected and centrifuged at 20.0006g (4uC) for 20 minutes. The
supernatants were concentrated by a factor of 100 on an Edwards
Micromodulyo lyophilisator and ZEA concentrations measured by
HPLC as described above. ZEA content was also quantified by
HPLC in the bacterium free ZEA sample.
For each individual animal, doses were calculated daily. ZEA
intake was 5 mg/kg bw.
2.8 Blood ZEA concentration measurement by
competitive fluorescent-microsphere based
immunoassay (CFIA)
Plasma samples (250 ml) were incubated with b -glucuronidase
(5000 U, Sigma Aldrich Ltd.) at 37uC for 24 h [27]. After
glucuronidase treatment, the samples were frozen, at 220uC for
5 minutes then the samples were diluted 20 fold in phosphate
buffered saline (PBS, pH 7.4) and loaded on a specific immu-
noaffinity Zearelenone column (IAC, ZearaStar COIAC 4000).
The column was washed with 20 ml PBS/TrX.
Flow cytometric analysis. The measurment of ZEA con-
centration in the isolated fraction of the blood sample by the
affinity column was performed using Fungi VI kit (Cat#503106,
Soft Flow Hungary R& D Ltd., Pecs, Hungary), The flow cytometric
measurements were performed on BD FACSArrayTM Bioanaly-
zer. Data analysis was carried out using FCAP 3.0 software.
Zearalenone Biodegradation Using R. pyridinivorans
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2.9 The evaluation of the Estrogen-dependent gene
expression at transcription level
For total RNA isolation uteri horns were homogenized in
500 ml TRI Reagent (Ambion). Total RNA was isolated using
Total RNA Mini Kit (Geneaid) according to the manufacturer’s
instructions. To eliminate genomic DNA contamination DNase I
treatment was introduced (1 U/reaction, reaction volume: 50 ml
RNase-free DNase I, Fermentas). Sample quality control and the
quantitative analysis were carried out by NanoDrop (Thermo
Scientific). cDNA synthesis was performed with the High Capacity
cDNA Reverse Transcription Kit (Life Technologies) according to
the manufacturer’s instructions.
The chosen primer sequences [22] used for the comparative CT
experiments were verified with the Primer Express 3.0 program.
The sequences are as follows:
Acidic ribosomal phosphoprotein P0 (ARBP; RefSeq:
NM_022402):
Forward: CCT AGA GGG TGT CCG CAA TGT G
Reverse: CAG TGG GAA GGT GTA GTC AGT CTC
Apelin (APLN; RefSeq: NM_031612):
Forward: TCT CAC CCA CCA AGT TCC TCT AAT G
Reverse: GGT CTC CAA GGG CAG TCC AAG
Aquaporin 5 (AQP5; RefSeq: NM_012779):
Forward: CCG CTT TGG AAT CAG GCA GAA TG
Reverse: TGG CAC TTG AGA TAC TGG GTT GG
Complement C2 (C2; RefSeq: NM_172222):
Forward: CCA CCA ATC CCA TCC AGA AGA GG
Reverse: TGA GAG GCA TCA AGC AGC AGA TAG
Calbindin-3 (CALB3; RefSeq: NM_012521):
Forward: TAG GAT TCA ATC AGT AGG TGG TGT CG
Reverse: GAT AAG AAC GGT GAT GGA GAA GTT AGC
The primers (Invitrogen) were used in real-time PCR reaction
with Fast EvaGreen qPCR Master Mix (Biotium, USA, CA) on an
ABI StepOnePlus instrument. The gene expression was analyzed
using the ABI StepOne 2.1 program. The amplicons were tested
by Melt Curve Analysis on an ABI StepOnePlus instrument.
Experiments were normalized to ARBP expression.
2.10 Statistical analysis
Data are presented as mean 6 S.E.M. Statistical significance
was calculated with one-way ANOVA and after that we checked
the differences with the Dunnet’s post hoc test. For multiple
comparisons were used Statistica 8.0 software. For the correlation-
and multiple regression analyses were used the MedCalcH 10
software. Differences with a P-value ,0.05 were considered
significant.
Results
3.1 Degradation experiments to analyze ZEA
biodegradation efficiency by HPLC and BLYES
Analyses of the pellet by HPLC detected lower than 1% residual
ZEA content of the original concentration (5 mg/ml), thus ZEA
elimination from the matrix was attributed to metabolic activity.
At the end of the 120 hours (5 days) incubation period 0.536mg/
ml ZEA concentration was measured from the culture supernatant
by HPLC. This represents 87.21% (6 2.83) degradation efficiency
(data not show).
The result of the BLYES based estrogenic biotest showed good
correlation with the analytical ZEA concentration measurement at
the end of the 5th day (Fig. 1). The analytical method showed
87.21% ZEA degradation in the supernatant of K408, while
BLYES showed a reduction of 81.75% in estrogen effects.
The time course of the ZEA degradation shows that after
24 hours, R. pyridinivorans K408 eliminated 44.64% of the
estrogenic effects of ZEA. Then the concentration remained
stable for 72 hours, after which the BLYES tester strain indicated
56% decrease in biological activity. The degradation developed by
the fifth day of the experiment reaching 81.75%.
3.2 Animal studies for detecting the effect of different
ZEA dose administration (Experiment 1)
In Experiment 1 the effects of zearalenone have been examined
on body weight, uterus weight and on the expression of estrogen
sensitive genes. In addition, plasma ZEA concentration was
measured by CFIA.
3.2.1 Effect of ZEA on body weight. 3 days administration
of ZEA did not result in any significant change in body weight:
The average body weight gain during the experiment was
11.0860.58 g and was not different in the different groups.
3.2.2 Blood ZEA concentration measurement by
CFIA. As shown on Figure 2, there was a dose dependent
increase in plasma ZEA concentration following oral administra-
tion of the mycotoxin. The lowest dose (0.1 mg/kg) did not result
in an increase of ZEA level in the plasma following 3 days
exposure compared to vehicle treated control prepubertal female
rats. The 1 mg/kg bw dose caused significantly elevated blood
ZEA levels (39.69610.20 ng/ml ANOVA, F.:20.49, p = 0.006).
The 5 mg/kg bw administration caused yet higher ZEA levels in
blood plasma (ANOVA: F= 8.59, p = 0.03). The highest concen-
tration of ZEA (10 mg/kg bw) did not significantly increase further
the blood plasma levels of ZEA (ANOVA: F= 2.51, p= 0.16)
compared to the 5 mg/kg ZEA group. Blood plasma levels of ZEA
showed a strong positive correlation (R = 0.919 p,0.01) with
uterus weight in a dose dependent manner (not shown).
3.2.3 Uterotrophic assay. Treatments of ZEA in 0.1 and
1 mg/kg bw doses had no significant effect on uterine weight. In
contrast, the 5 and 10 mg/kg bw ZEA and 0.04 mg/kg bw E2
administration resulted in increased relative uterine weight.
Positive control treatment (E2; 0.04 mg/kg bw) and highest dose
ZEA (10 mg/kg bw) resulted in approximately 3.8-fold increase of
uterine weight. Administration of ZEA in 5 mg/kg bw doses
resulted in a 2.4-fold increase (Fig. 3A).
3.2.4 Estrogen-dependent gene expression. Four validat-
ed genes were chosen for use in this study, with regards to
Heneweer et al. [22]. These genes were apelin (APLN), aquaporin
5 (AQP5), complement component 2 (C2) and calbindin-3
(CALB3). Initially the suitability of this method was verified by
using ZEA at 10 mg/kg bw and E2 at 0.04 mg/kg bw (Experiment
1). For this purpose we presented a quantitative real-time PCR
measurement with the samples using the same oligonucleotide
primers used in Heneweer’s study, as described. Gene expression
levels of APLN and AQP5 are decreased following ZEA and E2
treatment (Fig 4 A, B). Expression of C2 and CALB3 genes are
increased following ZEA and E2 treatment (Fig. 4C, 4D).
3.3 Evaluating of ZEA biodegradation (Experiment 2)
3.3.1 Effect of ZEA on body weight. The Experiment 2
demonstrated the effect of microbially decontaminated ZEA, and
its metabolites, to female prepubertal rats. ZEA containing LB
medium with or without R. pyridinivorans K408 had no significant
effect on body weight gain.
3.3.2 Evaluating of ZEA biodegradation with uterotrophic
assay. In Experiment 2., following the experience gained in
Experiment 1, uterine weight as a morphological marker was
monitored. A significant increase in uterine weight (2.6-fold as
compared to the control group) was noted following treatment
Zearalenone Biodegradation Using R. pyridinivorans
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with non-incubated zearalenone solution (ZEA). The other two
experimental groups (control and ZEA + R. pyridinivorans) yielded
similar results. Comparing the results of the ZEA group with the
ZEA + R. pyridinivorans group, it can be established that incubation
with the microbe decreased the uterotrophic effect by 2.6-fold
(Fig. 3B).
3.3.3 Evaluating of ZEA biodegradation with estrogen-
dependent gene expression. Results confirmed that incuba-
tion with R. pyridinivorans K408 decreased estrogen-dependent
effects of zearalenone-contaminated LB media. Treatment with
ZEA resulted in similar alterations in gene expression levels as
demonstrated in Experiment 1. Expression levels of APLN and
AQP5 are decreased whereas expression levels of C2 and CALB3
are increased significantly (Fig. 5). However there are no
significant differences in folding change between control and
ZEA + R. pyridinivorans treatment.
Discussion
This study has demonstrated that R. pyridinivorans K408
efficiently degrade ZEA without producing active estrogenic
metabolites.
There are different physical, chemical and biological strategies
for Zearalenone (ZEA) decontamination, such as adsorbents [28]
pulsed light technology [29], ozone gas oxidation [30], planti-
bodies [31] and cropping genetically modified maize that produce
ZEA-degrading enzymes [32]. Biodegradation seems to be the
most promising approach, with regards to ZEA decontamination.
There are several reports on ZEA biodegradation by microorgan-
isms including bacteria and fungi, however vast majority of these
transformations cannot be regarded as detoxification since the
estrogenic activities of these metabolites were not elucidated or
remained similar to that of ZEA [33]. Among those microbial
examples with known effective biodegradation properties, where
detailed measurements of toxicological and estrogenic effects of the
metabolites were performed, is the case of fungus Trichosporon
mycotoxinivorans. In this case, the loss of estrogenic activity of ZEA
and its derivatives was tested by simply using estrogen bioindicator
yeast strain YZRM7. Animal models were not used [34].
Similarly, the estrogenic effects of ZEA degradation using
Clonostachys rosea, was not investigated living animal models [35].
A further example, using the eubacterial Pseudomonas putida ZEA-1
strain, ZEA degradation ability was investigated only by use of the
Artemia salina based toxicity bioassay [16]. The use of an animal
model for testing the EDC effects of the arising metabolites
increases the reliability of monitoring the mycotoxin degradation.
This study utilized several analytical techniques and different
bioassays to reveal the endocrine modifying effects of ZEA
degradation products. First, the efficiency of ZEA-degradation was
measured by analytical methods. The ZEA-concentration of
supernatant, which arose during biodegradation, was measured
by HPLC-FLD which demonstrated efficient degradation. How-
ever, the use of HPLC alone could not provide information about
bioactive properties of degraded mycotoxin. Consequently, in-
vitro methods are needed.
ZEA (and other estrogenic compounds) stimulates the prolifer-
ation of MCF-7 human adenocarcinoma cells [7] where estrogenic
activity is proportional to neoplastic cell number. Detection could
be significantly simplified with transfected cell lines which contain
estrogen receptor genes and a reporter gene construct. The
disadvantage of this method is the usage of mammalian cells which
could be more complicated than bacteria and yeasts. This
drawback can be avoided through the use of the luciferase assay.
In this study BLYES was used which is suitable for high-
throughput screening of estrogenic molecules and ZEA-degrading
microbes. The animals metabolize ZEA into two major metab-
olites, a-zearalenol (a-ZOL) and b-zearalenol (b-ZOL), which are
also ligands of ER [6]. The metabolite a-ZOL shows a higher
estrogenic activity than ZEA, by contrast b-ZOL was less effective
in ER binding assay [36]. Our results showed that incubation the
zearalenon contaminated bacterial media (LB) with Rhodococcus
pyridinivorans K408 did not increased the bioluminescence of yeast
cells, the indicators of estrogenic activity. It seems that R.
pyridinivorans K408 metabolizes ZEA without the production of
estrogenic compounds, such as a- and b-ZOL, These results were
confirmed with a bioassay using prepubertal rat uterotrophic
assay. The animal experiments demonstrated that change in
uterine weight is unequivocal evidence of an estrogenic effect. The
circulating level of ZEA, and its metabolites, in the blood showed a
positive correlation with the uterine weight. The enterohepatic
ZEA circulation maintains a steady-state zearalenone concentra-
tion and increases the toxic effect of the ZEA and its derivates via
extend their biological half-life [37–38]. A previous study
examined the changes in expression of estrogen-responsive genes
(APLN, AQP5, C2 and CALB3) via mRNA level changes using
qRT-PCR [22]. In this study, gene expression levels of APLN and
AQP5 are decreased following treatment with ZEA and E2 while
expression of C2 and CALB3 genes show an increase following
ZEA and E2 treatment in Experiment 1. The uterotrophic
bioassay demonstrated no significant change in expression of the
investigated genes in the uteri of the control and ZEA + R.
pyridinivorans K408 treated animals in Experiment 2. The
endocrine disruptor effect of ZEA and its derivatives are
eliminated during incubation with R. pyridinivorans K408. There
are few microorganisms able to metabolize ZEA and eliminate
efficiently their endocrine modifying effect. The details of the
degradation mechanisms were presented the Clonostachys rosea and
Trichosporon mycotoxinivorans species alone.The plant pathogen
Clonostachys rosea (previously known as Gliocladium roseum) NRRL
1859 strain was capable of metabolizing zearalenone in 80–90%
yields. The product was a 1:1 mixture of 1-(3,5-dihydroxyphenyl)-
109-hydroxy-1-undecen-69-one and 1-(3,5-dihydroxyphenyl)-69-
hydroxy-1-undecen-109-one which were determined via spectros-
copy analysis. These metabolites showed far less estrogenic effects
then ZEA [39] Kakeya and coworkers isolated another strain,
Clonostachys rosea IFO 7063, which is able to degrade zearalenone
without arising estrogenic metabolites. They could purify the
lactonohydrolase enzyme (zhd101) which is responsible for the
degradation mechanism [35]. The structure of the arising
metabolite (1-(3,5-dihydroxyphenyl)-109-hydroxy-1-undecen-69-
one) was also determined by 2D NMR spectroscopy. This
compound did not show estrogenic activity in the human breast
cencer MCF-7 cell proliferation assay [40]. The yeast strain
Trichosporon mycotoxinivorans is also capable to efficiently degrade
zearalenone to non-estrogenic compounds [41]. The metabolite
was identified as (5S)-5-({2,4-dihydroxy-6-[(1E)-5-hydroxypent-1-
en-1-yl]benzoyl}oxy) hexanoic acid via NMR spectroscopy. This
metabolite did not interact with the human estrogen receptor in an
in vitro competitive binding assay [34]. The identified cleavage
positions of the Clonostachys rosea and Trichosporon mycotoxinivorans
strain?s enzymes on the ZEA molecule were summarised in
Figure 6. These data suggest that one putative mechanism of the
zaearalenone degradation by Rhodococcus pyridinivorans K408 could
be the opening of the lactone ring in the ZEA molecule, losing of
their estrogenic activity. On the other hand it is also possible that
the microbe could open up the aromatic ring as the strains of
Rhodococcus pyridinivorans have versatile metabolic pathways and the
most of them are able to degrade aromatic compounds like
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pyridine, styrene and BTEX (benzene, toluene, ethylbenzene, and
xylenes) chemicals as well [42,43,44,45,46] (Fig. 6).
The second achievement in this study is the application of a
novel microbe which is not only able to degrade ZEA effectively,
but also bioactive estrogenic metabolites did not arise during
biodegradation. Consequently Rhodococcus pyridinivorans K408 can
be used to decontaminate raw materials, and foodstuffs, by
reducing the ZEA concentration. After elucidating the metabolic
pathway of ZEA and isolating the enzymes which participate in its
degradation, an additive could feasibly be developed and thus
reducing the harmful effects on livestock. It is not only feed can be
decontaminated using the microbe but also distillers dried grains
with soluble (DDGS) occurred by bioethanol production from
maize [47].
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